PharmA-B-C SRL
The score of PharmA-B-C shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +58 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmA-B-C's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 1,873 € | ||||
| Equity | −18,129 € | ||||
| Cash | 83,766 € | ||||
| EBITDA | 23,013 € | ||||
| Total assets | 186,659 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 11 Sep 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 02 Aug 2022
PharmA-B-C's financial analysis
- Solvency-9.7%sector median: 52.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmA-B-C
PharmA-B-C's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0563.344.722
- VAT number
- BE0563344722
- Peppol
- Registered · 0208:0563344722 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2014
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Public relations and communication activities (NACE 73300)
PharmA-B-C (SRL) has been based in Waterloo since 2014, active in: public relations and communication activities. For 2025, it reports a net profit of 1,873 € and equity of −18,129 €; its revenue is not published. Its solvency stands at -9.7%, below the median of its sector (52.0%).
Companies similar to PharmA-B-C
Companies in the same business, of comparable size and area, outside its group.
- PMB Consulting Public relations and communication activities Sprimont · balance sheet 187,125 €
- IPMG Public relations and communication activities Hoeilaart · balance sheet 185,826 €
- cHReative Consulting Public relations and communication activities Jodoigne · balance sheet 185,483 €
- LSR Management Public relations and communication activities Grimbergen · balance sheet 185,434 €
- Nextview Public relations and communication activities Hoeilaart · balance sheet 185,186 €
- Embedded Engineering Public relations and communication activities Zonhoven · balance sheet 189,404 €
- Improvement & Consultancy Enterprise Public relations and communication activities Hoeilaart · balance sheet 183,911 €
- P2S Management Consulting Public relations and communication activities Brussels · balance sheet 189,558 €
Frequently asked questions about PharmA-B-C
What is the revenue of PharmA-B-C?
PharmA-B-C files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of PharmA-B-C?
In Belgium, the VAT number is the company number prefixed with BE: BE0563344722 for PharmA-B-C, if the company is VAT-registered. Its company number (CBE) is 0563.344.722.
Where is the registered office of PharmA-B-C?
According to the CBE register, the registered office of PharmA-B-C is in 1410 Waterloo.
What is the equity of PharmA-B-C?
At the close of the 2025 financial year, the equity of PharmA-B-C amounts to -18,129 €, a solvency of -9.7% of total assets.
Who manages PharmA-B-C?
The register lists 1 active mandates at PharmA-B-C. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmA-B-C
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →